Stay updated on Subcutaneous CDX-0159 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.

Latest updates to the Subcutaneous CDX-0159 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a Locations section with a Nebraska site (Lincoln, Nebraska). Removed the prior Nebraska Locations content and the HHS Vulnerability Disclosure link; updated revision to v3.3.3.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page footer, signifying a small site update.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page no longer displays a general funding/operating status notice, which was a site-wide message rather than part of the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe new screenshot shows only minor layout and formatting adjustments to the study page, with no changes to the core study details such as title, conditions, interventions, outcomes, eligibility, locations, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference6%

- Check98 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous CDX-0159 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.